Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 986 participants.

Also called NCT02662569

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 986 participants (enrolled count) (from the registry)
Sponsor
  • Amgen Registry lists this organization as the lead sponsor
Registry
  • NCT NCT02662569
  • EudraCT 2013-000723-14
Other papers using this trial's data
  • Randomized study of evolocumab in patients with type 2 diabetes and dyslipidaemia on background statin: Pre-specified analysis of the Chinese population from the BERSON clinical trial Diabetes, obesity & metabolism, 2019-06 DOI, PubMed 30851062, PMC6594089 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Argentina, Brazil, Canada, China, Colombia, France, Russia, South Korea, Türkiye (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT02662569. Randomized; quadruple masking; primary purpose treatment. Start 2016-04-14 (actual); primary completion 2017-12-06 (actual). Results posted on 2019-01-11.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia
Acronym
BERSON
Condition
Diabetes, Hyperlipidemia, Mixed Dyslipidemia
Intervention (Biological)
Evolocumab
Intervention (Drug)
Atorvastatin
Intervention (Other)
Placebo
Lead sponsor
Amgen (class: industry)

Record details

Record id
cardio:ct-nct02662569
Content hash
5a613d99c9d652da68fad350349e36664b073008d382d81546899179118d0b5f